These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2006-004950-25||WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study||2018-04-17||due-trials|
|Exempt, with results||2011-001788-36||A Phase I/II study to investigate the safety of Adenovirus specific T cells given to high-risk paediatric patients post allogeneic haematopoietic stem cell transplant (allo-HSCT) to treat reactivation...||2016-12-31||not-yet-due|
|Reported results||2013-004380-31||A Phase 2 open label study to investigate the efficacy of autologous EBV-specific T-cells for the treatment of patients with aggressive extranodal NK/T-cell lymphoma (ENKTCL).||2018-09-05||due-trials|
|Reported results||2014-003111-10||A single arm Phase I/II study of the safety and efficacy of gene-modified WT1 TCR therapy in patients with myelodysplastic syndrome (MDS) or acute myeloid leukaemia (AML) who have failed to achieve or...||2018-05-15||due-trials|